What makes us different from other trading websites and investment newsletters?
Value. Your monthly subscription costs about as much as you pay your broker for one or two option trades.
Accountability. Unlike other sites, we don't just drop trades and walk away. Phil Davis, David Ristau and Optrader are on-line most trading days to talk to you live. How's that for backing up our trade ideas? We follow our trades through from open to close and we're there for you to help analyze your own trades and look for ways to improve them.
Exclusivity. You can’t make trades with 10,000 other people - it just doesn’t work! We limit our membership to give everyone a chance to pick up the positions we spot.
Community. Come for the great calls…stay for the great conversation. Our active daily forum is unique – no other investment newsletter or trading service has such a busy community of informed members offering their own opinions, ideas, and input.
Phil is often an active participant, not just a name on the marquee. If you’re an amateur or professional trader, you’ll find that our members are some of the smartest and most experienced around. No matter who you are, you’ll benefit from the dialogue our subscribers have with each other every single day.
A message from Phil:
There’s nothing I hate more than people who tell you what you would have made if you had done some perfect entry and perfect exit on a trade they vaguely recommended out of dozens that didn’t work out. It’s never going to happen here!
We keep a running archive of every single post and ever single trade idea since November of 2005 so you can see for yourself what you think of our picks! Do I need your credit card so you can look? No, why should I - the work should stand on their own. If you think they would have helped you in the past then you may decide on your own whether you want to sign up for our daily live site.
How can we give all that away for free? Because our performance is not a fluke, we do this all the time and we’re pretty sure there will be brand new trading opportunities for us tomorrow - the old ideas you can keep with our compliments!
This is not your run-of-the-mill dry, financial reporting! According to Google, there are 11,500,000 stock picking pages on the web and they all think they’re smarter than us… We don’t try to out shout the masses - we just try to have some fun and make some money! Now I’ve been told by marketing experts that I need to put in giant letters that say we make more trades, more often than most newsletters (we do), that I should make a big deal about how we try to pick real, well-known companies that are fairly liquid so you can get your money in and (more importantly) out and I’m supposed to make a big deal about beating the markets month after month (we do). I’m not going to do that...
When I used to look for a financial newsletter I would always read that stuff and go “blah blah blah” in my head until I found some kind of sample of the actual trading. Well, we give you full access to our posted trade ideas and, when you sign up for a FREE trial of the PSW report, you can even view EVERY SINGLE comment and trade idea in our premium member chat from the past 7-30 days. All the winners and all the losers, not just selected “samples”. There’s also a weekly update free, right on this site and you can take a look most Fridays or Saturdays for yourself and you can check out my style for yourself and decide if it would annoy or please you to read me every day.
All right, so I’m not good at marketing - but that’s not why you’re here is it? I am an amateur investor, like you, who just got sick of all the BS I was getting from all the “professional” services and I decided to start my own. I’m not a broker or a pro trader and you would be nuts to make any trade you read about here without consulting a professional financial advisor as to its suitability for your virtual portfolio… But, if you like to talk about stocks and pick up some tips that might work without all the hype and nonsense - come join us!
So why listen to me? I do have sort of a knack for spotting trends and picking winners and I’m happy to share what I know with you. No other reason. Nothing bad will happen to you if you don’t sign up with us - there is no pressure and this is not a limited offer. Come back any time we are accepting new members - the door will always be open. Looking forward to meeting you, - Phil
This is a non-trading topic, but I wanted to post it during trading hours so as many eyes can see it as possible. Feel free to contact me directly at firstname.lastname@example.org with any questions.
Last fall there was some discussion on the PSW board regarding setting up a YouCaring donation page for a PSW member, Shadowfax. Since then, we have been looking into ways to help get him additional medical services and to pay down his medical debts. After following those leads, we are ready to move ahead with the YouCaring site. (Link is posted below.) Any help you can give will be greatly appreciated; not only to help aid in his medical bill debt, but to also show what a great community this group is.
Remember those weird kids who didn’t say the Pledge of Allegiance in school? They either sat down or just stood up silently. I sure do. Most likely for religious reasons, but I remember thinking to myself as a kid that it was wrong not to say the pledge aloud with the rest of us. As I got older in my teenage years, I even felt that those kids were not being respectful.
Some adults may even give them the old, “well, if you don’t like it then you can leave” routine that is mentioned every time a minority opts out of th...
Here is a preview of the monthly moving averages I track after the close of the last business day of the month. All three S&P 500 strategies are now signaling "invested" -- unchanged from last month. Two of the five of the Ivy Portfolio ETFs, the PowerShares DB Commodity Index Tracking (DBC and the Vanguard FTSE All-World ex-US ETF (VEU), are signal cash "cash" -- also unchanged from last month.
If a position is less than 2% from a signal, it is highlighted in yellow.
Note: My inclusion of the S&P 500 index updates is intended to illustrate a popular moving moving-average timing strategy. The index signals also give a general sense of how US equities are behaving. Howe...
Bulls showed renewed backbone last week and drew a line in the sand for the bears, buying with gusto into weakness as I suggested they would. After all, this was the buying opportunity they had been waiting for. As if on cue, the start of the World Series launched the rapid market reversal and recovery. However, there is little chance that the rally will go straight up. Volatility is back, and I would look for prices to consolidate at this level before making an attempt to go higher. I still question whether the S&P 500 will ultimately achieve a new high before year end.
In this weekly update, I give my view of the current market environment, offer a technical analysis of the S&P 500 chart, review our weekly fundamentals-based SectorCast rankings of the ten U.S. business sectors, and then o...
Reminder: OpTrader is available to chat with Members, comments are found below each post.
This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).
We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options.
Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.
To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here
If you're following Valeant's proposed takeover (or merger) of Allergan and the lawsuit by Allergan against Valeant and notorious hedge fund manager William Ackman, for insider trading this is a must-read article.
Linette Lopez describes the roles played by key Wall Street hedge fund owners--Jim Chanos, John Paulson, and Mason Morfit, a major shareholder in Valeant. Linette goes through the con...
There is lots of action in Southwest Airlines Co. November expiry call options today ahead of the air carrier’s third-quarter earnings report prior to the opening bell on Thursday. Among the large block trades initiated throughout the trading session, there appears to be at least one options market participant establishing a call spread in far out of the money options. It looks like the trader purchased a 4,000-lot Nov 37/39 call spread at a net premium of $0.40 apiece. The trade makes money if shares in Southwest rally 9.0% over the current price of $34.32 to exceed the effective breakeven point at $37.40, with maximum potential profits of $1.60 per contract available in the event that shares jump more than 13% to $39.00 by expiration. In September, the stock tou...
Now that bitcoin has subsided from speculative bubble to functioning currency (see the price chart below), it’s safe for non-speculators to explore the whole “cryptocurrency” thing. So…is bitcoin or one of its growing list of competitors a useful addition to the average person’s array of bank accounts and credit cards — or is it a replacement for most of those things? And how does one make this transition?
With his usual excellent timing, London-based financial writer/actor/stand-up comic Dominic Frisby has just released Bitcoin: The Future of Money? in which he explains all this in terms most readers will have no tr...
Reminder: Pharmboy is available to chat with Members, comments are found below each post.
Well PSW Subscribers....I am still here, barely. From my last post a few months ago to now, nothing has changed much, but there are a few bargins out there that as investors, should be put on the watch list (again) and if so desired....buy a small amount.
First, the media is on a tear against biotechs/pharma, ripping companies for their drug prices. Gilead's HepC drug, Sovaldi, is priced at $84K for the 12-week treatment. Pundits were screaming bloody murder that it was a total rip off, but when one investigates the other drugs out there, and the consequences of not taking Sovaldi vs. another drug combinations, then things become clearer. For instance, Olysio (JNJ) is about $66,000 for a 12-week treatment, but is approved for fewer types of patients AND...
Note: The material presented in this commentary is provided for
informational purposes only and is based upon information that is
considered to be reliable. However, neither PSW Investments, LLC d/b/a PhilStockWorld (PSW)
nor its affiliates
warrant its completeness, accuracy or adequacy and it should not be relied upon as such. Neither PSW nor its affiliates are responsible for any errors or omissions or for results obtained from the use of this information. Past performance, including the tracking of virtual trades and portfolios for educational purposes, is not necessarily indicative of future results. Neither Phil, Optrader, or anyone related to PSW is a registered financial adviser and they may hold positions in the stocks mentioned, which may change at any time without notice. Do not buy or sell based on anything that is written here, the risk of loss in trading is great.
This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities or other financial instruments mentioned in this material are not suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only intended at the moment of their issue as conditions quickly change. The information contained herein does not constitute advice on the tax consequences of making any particular investment decision. This material does not take into account your particular investment objectives, financial situations or needs and is not intended as a recommendation to you of any particular securities, financial instruments or strategies. Before investing, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.
Site owned and operated by PSW Investments, LLC. Contact us at: 403 Central Avenue, Hawthorne, NJ 07506. Phone: (201) 743-8009. Email: email@example.com.